News

Acorda Therapeutics announces Inbrija Approved in US to Treat Off Periods in Parkinson’s Patients on Carbidopa/Levodopa

February 28, 2019 — Acorda Therapeutics issued a press release announcing that INBRIJA is now available by prescription in the United States. INBRIJA (levodopa inhalation powder) is a prescription medicine used for the return of Parkinson’s symptoms (known as OFF episodes) in people treated with carbidopa-levodopa medicines. INBRIJA does not replace regular carbidopa-levodopa medicines.
Read More http://www.acorda.com/products/products/inbrija

Follow Us Follow us on TwitterFollow us on FacebookInstagram

Sign Up for Email Alerts

By providing your email you agree to receive periodic emails from The Parkinson Alliance.

Please tell us more about yourself:

This month is? (Anti-Spam)

Contact UsTerms Of UsePrivacy Policy

The Parkinson Alliance is a nonprofit, tax-exempt charitable organization under section 501(c)(3) of the Internal Revenue Code. Donations are tax-deductible as allowed by law. Copyright © 2018 The Parkinson Alliance. All rights reserved.